Sharkey Howes & Javer Invests $410,000 in HCA Healthcare, Inc. (NYSE:HCA)

Sharkey Howes & Javer bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, HoldingsChannel reports. The fund bought 1,010 shares of the company’s stock, valued at approximately $410,000.

A number of other large investors also recently modified their holdings of HCA. Terra Nova Asset Management LLC grew its stake in shares of HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after buying an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV raised its position in HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management increased its stake in shares of HCA Healthcare by 0.7% in the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares during the period. UMB Bank n.a. boosted its position in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares during the period. Finally, Lake Street Advisors Group LLC raised its stake in shares of HCA Healthcare by 1.3% during the second quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock valued at $878,000 after acquiring an additional 35 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft lifted their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. Oppenheimer lifted their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Finally, Barclays lifted their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $365.65.

HCA Healthcare Stock Down 0.4 %

HCA traded down $1.70 during mid-day trading on Monday, reaching $413.84. 365,151 shares of the stock were exchanged, compared to its average volume of 1,136,178. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The company has a 50 day moving average price of $392.18 and a two-hundred day moving average price of $350.50. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $417.14. The stock has a market capitalization of $108.39 billion, a PE ratio of 20.71, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter in the previous year, the business earned $4.29 EPS. The company’s revenue was up 10.3% compared to the same quarter last year. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were paid a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.64%. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Activity at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.